Get the Stockscreener App
15.10
2.01%
-0.31
After Hours:
15.20
0.10
+0.66%
Omada Health Inc stock is traded at $15.10, with a volume of 745.18K.
It is down -2.01% in the last 24 hours and down -29.60% over the past month.
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The Company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.
See More
Previous Close:
$15.41
Open:
$15.42
24h Volume:
745.18K
Relative Volume:
1.05
Market Cap:
$874.41M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-13.66%
1M Performance:
-29.60%
6M Performance:
-12.11%
1Y Performance:
+0.00%
1-Day Range:
$14.94
$15.45
1-Week Range:
$14.86
$17.47
52-Week Range:
$14.14
$26.91
Omada Health Inc Stock (OMDA) Company Profile
Name
Omada Health Inc
Sector
Industry
Phone
888-987-8337
Address
611 GATEWAY BLVD., SOUTH SAN FRANCISCO
Compare OMDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMDA
Omada Health Inc
|
15.10 | 892.36M | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
223.26 | 37.72B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
70.61 | 13.14B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
96.79 | 8.32B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
43.85 | 8.31B | 550.17M | 201.35M | 232.07M | 1.00 |
|
BTSG
Brightspring Health Services Inc
|
36.54 | 6.47B | 11.99B | 24.18M | 234.31M | 0.2956 |
Omada Health Inc Stock (OMDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Sep-05-25 | Initiated | Robert W. Baird | Neutral |
| Jul-01-25 | Initiated | Barclays | Overweight |
| Jul-01-25 | Initiated | Canaccord Genuity | Buy |
| Jul-01-25 | Initiated | Evercore ISI | Outperform |
| Jul-01-25 | Initiated | Goldman | Buy |
| Jul-01-25 | Initiated | JP Morgan | Overweight |
| Jul-01-25 | Initiated | Morgan Stanley | Overweight |
| Jul-01-25 | Initiated | Needham | Buy |
View All
Omada Health Inc Stock (OMDA) Latest News
With A 26% Price Drop For Omada Health, Inc. (NASDAQ:OMDA) You'll Still Get What You Pay For - simplywall.st
Omada Health (NASDAQ:OMDA) Trading Down 5.1%What's Next? - MarketBeat
Shareholders Should Be Pleased With Omada Health, Inc.'s (NASDAQ:OMDA) Price - 富途牛牛
Digital Therapeutics Market to Reach US$ 39.52 Billion by 2033 - openPR.com
Omada Health (NASDAQ:OMDA) Shares Gap DownWhat's Next? - MarketBeat
Omada Health: Business Is Scaling Very Healthily (NASDAQ:OMDA) - Seeking Alpha
Franklin Resources Inc. Makes New Investment in Omada Health, Inc. $OMDA - MarketBeat
Digital Health Coaching Market Size Worth $28.40 Billion by 2032, Drive by AI-Driven Personalization and Rising Demand for Preventive Care – SNS Insider - GlobeNewswire Inc.
Is OMDA Stock Set for a Rebound? - StocksToTrade
Certain Stock Options of Omada Health, Inc. are subject to a Lock-Up Agreement Ending on 3-DEC-2025. - MarketScreener
Certain Warrants of Omada Health, Inc. are subject to a Lock-Up Agreement Ending on 3-DEC-2025. - marketscreener.com
Certain Common Stock of Omada Health, Inc. are subject to a Lock-Up Agreement Ending on 3-DEC-2025. - marketscreener.com
Certain Series A Preferred Stock of Omada Health, Inc. are subject to a Lock-Up Agreement Ending on 3-DEC-2025. - marketscreener.com
HBK Investments L P Invests $1.37 Million in Omada Health, Inc. $OMDA - MarketBeat
1,090,056 Shares in Omada Health, Inc. $OMDA Acquired by Loomis Sayles & Co. L P - MarketBeat
Omada Health, Inc. (NASDAQ:OMDA) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Omada Health, Inc.'s (NASDAQ:OMDA) Lock-Up Period To End on December 3rd - MarketBeat
Oversold Conditions For Omada Health (OMDA) - Nasdaq
Omada Health to Participate in Evercore Healthcare Conference - The Manila Times
United States 7MM Digital Therapeutics for Diabetes Market: FDA - openPR.com
Omada Health’s Strategic Growth and Profitability: A Buy Rating by Craig Hettenbach - TipRanks
Omada Health's Integrated Approach Powers Growth in Digital Therapeutics () - aktiencheck.de
OMDA: BMO Capital Initiates Coverage with "Outperform" Rating | - GuruFocus
Thought bubble: Omada's about-face - Axios
Omada Health initiated with an Outperform at BMO Capital - TipRanks
Omada Health Positioned for Growth with Strong Financial Performance and Strategic Market Opportunities - TipRanks
EBIT per share of Omada Health, Inc. – MUN:U76 - TradingView
Inside Omada's pivot toward GLP-1 prescriptions - Axios
Cash from financing activities of Omada Health, Inc. – FWB:U76 - TradingView
Omada Health Reports Strong Q3 2025 Growth - MSN
How Trump’s GLP-1 move may affect telehealth companies’ fortunes - Modern Healthcare News
Free cash flow per share of Omada Health, Inc. – MUN:U76 - TradingView
Omada Health, Inc. Earnings and Revenue – MUN:U76 - TradingView
Omada Health (OMDA): Assessing Valuation After Recent Stock Declines - Yahoo Finance
Latin America Digital Therapeutics Market Poised - openPR.com
Omada Health Stock Jumps Into Retail Focus As Wall Street Lifts Price Targets After ‘Beat And Raise’ Quarter, GLP-1 Push - Stocktwits
Omada Health, Inc. Balance Sheet – FWB:U76 - TradingView
Omada Health announces GLP-1 prescribing capability - MSN
Omada Health raises FY25 revenue view to $251.5M-$254.5M from $235M-$241M - MSN
Omada Health reports Q3 EPS (6c), consensus (7c) - MSN
Omada Health Reports Strong Growth and Innovation - MSN
Omada Health price target raised to $32 from $30 at Morgan Stanley - MSN
Needham & Company LLC Issues Positive Forecast for Omada Health (NASDAQ:OMDA) Stock Price - MarketBeat
Omada Health price target raised to $28 from $27 at Evercore ISI - MSN
Evercore ISI Group Maintains Omada Health (OMDA) Outperform Recommendation - MSN
Why Omada Health is finally prescribing Ozempic as TrumpRx slashes GLP-1 weight-loss drug costs - Business Insider
Omada Health Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Omada Health to prescribe GLP-1s - TechTarget
Evercore ISI Group Raises Price Target for OMDA to $28.00 | OMDA Stock News - GuruFocus
Omada Health, Inc.: Strong Revenue Momentum and Strategic Partnerships Drive Buy Rating - TipRanks
Omada Health to present RWE on behavior change program at ObesityWeek - MSN
Omada Health Inc Stock (OMDA) Financials Data
There is no financial data for Omada Health Inc (OMDA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.32%
6.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):